Tag Archives: Breast cancer

Breast cancer specialist reports advance in treatment of triple-negative breast cancer

“Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-Per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)” was accepted as a rapid publication and published online this month by the Journal of Clinical Oncology. It will come out in print in September. Because of its rapid growth rate, many women with triple-negative breast cancer receive chemotherapy to try to shrink it before undergoing surgery. …

Symptoms after breast cancer surgery need to be treated on an individual basis — ScienceDaily

The authors state that it is crucial for good aftercare to understand and document a patient’s symptoms and target the treatment accordingly. Special attention will have to be paid to the risk of certain groups of patients: younger, premenopausal women suffer notably more from the effects of breast cancer than older women. In any case, women about to be given treatment for breast cancer should be given detailed information about late sequelae. source : http://www.sciencedaily.com/releases/2014/08/140826085730.htm

Genes found to be linked to breast cancer in East Asian women — ScienceDaily

While breast cancer is one of the most common malignancies among women worldwide, most studies of the genetic risk factors for the disease have focused on women of European ancestry. Given the differences in genetic heritage and environmental exposures between East Asian women and those of European ancestry, the investigators decided to conduct a study in East Asians to search for genetic changes that are linked to breast cancer development. The current study was conducted as part of the Asia Breast Cancer Consortium led by Wei Zheng, M.D., Ph.D., MPH, Ingram Professor of Cancer Research at Vanderbilt. …

High-fat diet during puberty speeds up breast cancer development

The research comes from the Breast Cancer and the Environment Research Program at Michigan State University and is published in the current online issue of Breast Cancer Research. Utilizing a preclinical model, the findings indicate that before any tumors appear, there are changes in the breast that include increased cell growth and alterations in immune cells. These changes persist into adulthood and can lead to the rapid development of precancerous lesions and ultimately breast cancer. In addition to the accelerated breast cancer development, this type of diet produces a distinct gene signature in the tumors consistent with a subset of breast cancers known as basal-like that can carry a worse prognosis. …

Breast cancer incidence rates converging among white, African American women

The finding is published in Breast Cancer Statistics, 2013 published in CA: A Cancer Journal for Clinicians, a peer-reviewed journal of the American Cancer Society. The report and its consumer version, Breast Cancer Facts & Figures 2013-2014, are published biennially and provide detailed analyses of breast cancer incidence, mortality, and survival trends, as well as information on early detection, treatment, and factors that influence risk and survival. An estimated 232,340 new cases of invasive breast cancer and 39,620 breast cancer deaths are expected to occur among U.S. women in 2013. …

Critical gaps discovered in breast cancer research

It is estimated that around 570,000 people are living with, or after, a diagnosis of breast cancer in the UK, and this number is expected to double by 2030. Breast cancer, therefore, remains a significant challenge. Over 100 specialist breast cancer scientists, clinicians and heath care professionals reviewed a wide range of issues and challenges involved in breast cancer research, prevention and treatment. Through facilitated discussions and consultation, including appraisal from experts and patients, they produced an account outlining ten major gaps and five strategic solutions. …

Biomarker predicts long-term risk of breast cancer recurrence

"We have validated a unique ‘fingerprint’ in the primary tumor of breast cancer patients that can help identify a high or low risk of cancer recurrence," says study co-author Paul Goss, MD, PhD, director of the Breast Cancer Research Program at Massachusetts General Hospital (MGH) Cancer Center. "This should enable us to offer prolonged treatment to patients who remain at risk and, importantly, to avoid the costs and side effects of treatment in those at low risk." Standard treatment for early-stage, ER-positive breast cancer includes five years of treatment with either tamoxifen or an aromatase inhibitor, drugs that block the action of estrogen. …

Breast cancer cells’ sugar craving is target for new type of treatment

The treatment exploits a novel link, identified by the scientists, between sugar processing in the cells and their growth and division. This approach to treating breast cancer offers a real alternative to chemotherapy as it targets the active cancer cells and not normal cells, reducing the risk of side effects that affect thousands of women undergoing treatment. Breast Cancer Campaign funded scientist, Dr Jeremy Blaydes at the University of Southampton, has shown for the first time that chemicals called cyclic peptide inhibitors can stop ‘sweet toothed’ cancer cells from growing and multiplying by blocking proteins in the cells called CtBPs (C-terminal binding proteins). …